Impact and interactions between smoking and traditional prognostic factors in lung cancer progression

Lung Cancer

Volumn 66, Issue 3, 2009, Pages 386-392

  Guo, Nancy L ^a   Tosun, Kursad ^a   Horn, Kimberly ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Adjuvant chemotherapy; Cigarette smoking; Non small cell lung cancer; Overall survival; Prognosis; Tumor differentiation; Tumor stage

Indexed keywords

ADULT; AGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING HABIT; TREATMENT FAILURE; TUMOR DIFFERENTIATION;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SMOKING; SURVIVAL ANALYSIS;

EID: 70350621084     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.02.012     Document Type: Article

References (45)

1. Christiani D.C. Genetic susceptibility to lung cancer. J Clin Oncol 24 10 April (11) (2006) 1651-1652
2. Hoffman P.C., Mauer A.M., and Vokes E.E. Lung cancer. Lancet 355 5 February (9202) (2000) 479-485
3. Spira A., and Ettinger D.S. Multidisciplinary management of lung cancer. N Engl J Med 350 22 January (4) (2004) 379-392
4. Hung R.J., McKay J.D., Gaborieau V., Boffetta P., Hashibe M., Zaridze D., et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452 3 April (7187) (2008) 633-637
5. Beer D.G., Kardia S.L., Huang C.C., Giordano T.J., Levin A.M., Misek D.E., et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8 August (8) (2002) 816-824
6. Potti A., Mukherjee S., Petersen R., Dressman H.K., Bild A., Koontz J., et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 355 10 August (6) (2006) 570-580
7. Bach P.B., Kattan M.W., Thornquist M.D., Kris M.G., Tate R.C., Barnett M.J., et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 95 19 March (6) (2003) 470-478
8. Gorlova O.Y., Amos C., Henschke C., Lei L., Spitz M., Wei Q., et al. Genetic susceptibility for lung cancer: interactions with gender and smoking history and impact on early detection policies. Hum Hered 56 1-3 (2003) 139-145
9. Spinola M., Meyer P., Kammerer S., Falvella F.S., Boettger M.B., Hoyal C.R., et al. Association of the PDCD5 locus with lung cancer risk and prognosis in smokers. J Clin Oncol 24 10 April (11) (2006) 1672-1678
10. Miura K., Bowman E.D., Simon R., Peng A.C., Robles A.I., Jones R.T., et al. Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. Cancer Res 62 1 June (11) (2002) 3244-3250
11. Yoshino I., Kawano D., Oba T., Yamazaki K., Kometani T., and Maehara Y. Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma. Ann Thorac Surg 81 April (4) (2006) 1189-1193
12. Gazdar A.F., and Minna J.D. Cigarettes, sex, and lung adenocarcinoma. J Natl Cancer Inst 89 5 November (21) (1997) 1563-1565
13. Thun M.J., Lally C.A., Flannery J.T., Calle E.E., Flanders W.D., and Heath Jr. C.W. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 89 5 November (21) (1997) 1580-1586
14. Fielding J.E. Smoking: health effects and control (1). N Engl J Med 313 22 August (8) (1985) 491-498
15. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 98 20 November (24) (2001) 13790-13795
16. Larsen J.E., Pavey S.J., Passmore L.H., Bowman R.V., Hayward N.K., and Fong K.M. Gene expression signature predicts recurrence in lung adenocarcinoma. Clin Cancer Res 13 15 May (10) (2007) 2946-2954
17. Raponi M., Zhang Y., Yu J., Chen G., Lee G., Taylor J.M., et al. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res 66 1 August (15) (2006) 7466-7472
18. AJCC cancer staging manual (2002), Springer
19. Kruskal W.H., and Wallis W.A. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 47 260 (1952) 583-621
20. Cox D. Regression models and life-tables (with discussion). J R Stat Soc, Ser B Meth 34 (1972) 187-220
21. Everitt B., and Hothorn T. A handbook of statistical analyses using R (2006), Chapman & Hall/CRC, Boca Raton, FL
22. Carbone D. Smoking and cancer. Am J Med 93 15 July (1A) (1992) 13S-17S
23. Denissenko M.F., Pao A., Tang M., and Pfeifer G.P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274 18 October (5286) (1996) 430-432
24. Vineis P., and Caporaso N. Tobacco and cancer: epidemiology and the laboratory. Environ Health Perspect 103 February (2) (1995) 156-160
25. Westra W.H., Slebos R.J., Offerhaus G.J., Goodman S.N., Evers S.G., Kensler T.W., et al. K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung. Cancer 72 15 July (2) (1993) 432-438
26. Westra W.H., Offerhaus G.J., Goodman S.N., Slebos R.J., Polak M., Baas I.O., et al. Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking. Am J Surg Pathol 17 March (3) (1993) 213-220
27. Westra W.H., Baas I.O., Hruban R.H., Askin F.B., Wilson K., Offerhaus G.J., et al. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res 56 1 May (9) (1996) 2224-2228
28. Bild A.H., Yao G., Chang J.T., Wang Q., Potti A., Chasse D., et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439 19 January (7074) (2006) 353-357
29. Hayes D.N., Monti S., Parmigiani G., Gilks C.B., Naoki K., Bhattacharjee A., et al. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. J Clin Oncol 24 1 November (31) (2006) 5079-5090
30. Shedden K., Taylor J.M., Enkemann S.A., Tsao M.S., Yeatman T.J., Gerald W.L., et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14 August (8) (2008) 822-827
31. Guo L., Ma Y., Ward R., Castranova V., Shi X., and Qian Y. Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Clin Cancer Res 12 1 June (11) (2006) 3344-3354
32. Center for Disease Control and Prevention. Morbidity and mortality weekly report. Tobacco use among adults-U.S., 2005; 2006, 1145 p.
33. Travis W.D., Travis L.B., and Devesa S.S. Lung cancer. Cancer 75 1 January (1 Suppl) (1995) 191-202
34. Ernster V.L. The epidemiology of lung cancer in women. Ann Epidemiol 4 March (2) (1994) 102-110
35. Levi F., Franceschi S., La V.C., Randimbison L., and Te V.C. Lung carcinoma trends by histologic type in Vaud and Neuchatel, Switzerland, 1974-1994. Cancer 79 1 March (5) (1997) 906-914
36. Cancer Epidemiology and Prevention. 2nd ed. (1996), Oxford University Press, New York, NY
37. Hackshaw A.K., Law M.R., and Wald N.J. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ 315 18 October (7114) (1997) 980-988
38. Peto R., Lopez A.D., Boreham J., Thun M., Heath Jr. C., and Doll R. Mortality from smoking worldwide. Br Med Bull 52 January (1) (1996) 12-21
39. Rachtan J., and Sokolowski A. Risk factors for lung cancer among women in Poland. Lung Cancer 18 October (2) (1997) 137-145
40. Wynder E.L., and Muscat J.E. The changing epidemiology of smoking and lung cancer histology. Environ Health Perspect November (103 Suppl 8) (1995) 143-148
41. Dresler C.M., Leon M.E., Straif K., Baan R., and Secretan B. Reversal of risk upon quitting smoking. Lancet 368 29 July (9533) (2006) 348-349
42. Doll R., Peto R., Boreham J., and Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 328 26 June (7455) (2004) 1519
43. Anthonisen N.R., Lindgren P.G., Tashkin D.P., Kanner R.E., Scanlon P.D., and Connett J.E. Bronchodilator response in the lung health study over 11 yrs. Eur Respir J 26 July (1) (2005) 45-51
44. Scanlon P.D., Connett J.E., Waller L.A., Altose M.D., Bailey W.C., and Buist A.S. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 161 February (2 Pt 1) (2000) 381-390
45. Brown C.A., Crombie I.K., Smith W.C., and Tunstall-Pedoe H. The impact of quitting smoking on symptoms of chronic bronchitis: results of the Scottish Heart Health Study. Thorax 46 February (2) (1991) 112-116